{"id":413504,"date":"2021-01-12T16:09:10","date_gmt":"2021-01-12T21:09:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=413504"},"modified":"2021-01-12T16:09:10","modified_gmt":"2021-01-12T21:09:10","slug":"brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/","title":{"rendered":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">CHELMSFORD, Mass.<\/span>, <span class=\"xn-chron\">Jan. 12, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0Brooks Automation, Inc. (Nasdaq:BRKS) \u00a0announced today that GENEWIZ, the Company&#8217;s genomics analysis business, has been awarded one of six \u00a0Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation&#8217;s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years.<\/p>\n<p>&#8220;This contract for Brooks to provide whole exome sequencing to the National Cancer Institute demonstrates the outstanding reputation of GENEWIZ in the cancer research community,&#8221; commented\u00a0Steve Schwartz, president and CEO of Brooks Automation. &#8220;We are proud that GENEWIZ&#8217;s expertise in gene sequencing is an enabling factor for the important research at the NCI, and for the enduring benefit of cancer patients.&#8221;\u00a0 <\/p>\n<p>&#8220;The data NCI generates for the entire cancer research community across the nation supports the mission to advance scientific knowledge and help all people live longer, healthier lives,&#8221; shared Dr. <span class=\"xn-person\">Ginger Zhou<\/span>, vice president of genomics services at GENEWIZ. &#8220;We are honored to become an integral part of this initiative.&#8221;<\/p>\n<p>GENEWIZ will generate data from DNA samples received from the Biospecimen Core Resource and send raw sequencing data, associated metadata, and other characterization data to the Genomic Data Commons. This data will then be shared with the Genomic Data Analysis Network and research community.<\/p>\n<p>The Center for Cancer Genomics coordinates research teams across <span class=\"xn-location\">the United States<\/span> and <span class=\"xn-location\">Canada<\/span> to produce rich cancer genomic and clinical datasets for the cancer research community. They implement these collective efforts through a standardized workflow called the <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3035293-1&amp;h=1593668172&amp;u=https%3A%2F%2Fwww.cancer.gov%2Fabout-nci%2Forganization%2Fccg%2Fresearch%2Fgenomic-pipeline%23genome-characterization&amp;a=Genome+Characterization+Pipeline\" rel=\"nofollow noopener noreferrer\">Genome Characterization Pipeline<\/a>. Components of this pipeline include tissue collecting and processing, genome characterization, genomic data analysis, as well as data sharing and discovery.<\/p>\n<p>\n        <b>About Brooks Automation<br \/><\/b>Brooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide.\u00a0The Company&#8217;s Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry&#8217;s top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences&#8217; GENEWIZ division is a leading provider of gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamination control solutions to the world&#8217;s leading semiconductor chip makers and equipment manufacturers.\u00a0Brooks is headquartered in\u00a0Chelmsford, MA, with operations in\u00a0North America,\u00a0Europe\u00a0and Asia.\u00a0For more information, visit\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3035293-1&amp;h=870027346&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3005930-1%26h%3D3053535646%26u%3Dhttp%253A%252F%252Fwww.brooks.com%252F%26a%3Dwww.brooks.com&amp;a=www.brooks.com\" rel=\"nofollow noopener noreferrer\">www.brooks.com<\/a>.<\/p>\n<p>BROOKS INVESTOR CONTACT:<br \/><span class=\"xn-person\">Sherry Dinsmore<\/span><br \/>Brooks Automation<br \/>978.262.4301<br \/><a target=\"_blank\" href=\"mailto:sherry.dinsmore@brooks.com\" rel=\"nofollow noopener noreferrer\">sherry.dinsmore@brooks.com<\/a><\/p>\n<p>\n        <span class=\"xn-person\">John Mills<\/span><br \/>\n        <br \/>Managing Partner<br \/>ICR, LLC<br \/>646.277.1254<br \/><a target=\"_blank\" href=\"mailto:john.mills@icrinc.com\" rel=\"nofollow noopener noreferrer\">john.mills@icrinc.com<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder7130\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg\" title=\"(PRNewsfoto\/Brooks Automation)\" alt=\"(PRNewsfoto\/Brooks Automation)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NE46672&amp;sd=2021-01-12\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute-301206883.html\">http:\/\/www.prnewswire.com\/news-releases\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute-301206883.html<\/a><\/p>\n<p>SOURCE  Brooks Automation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NE46672&amp;Transmission_Id=202101121605PR_NEWS_USPR_____NE46672&amp;DateId=20210112\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire CHELMSFORD, Mass., Jan. 12, 2021 \/PRNewswire\/ &#8212;\u00a0Brooks Automation, Inc. (Nasdaq:BRKS) \u00a0announced today that GENEWIZ, the Company&#8217;s genomics analysis business, has been awarded one of six \u00a0Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation&#8217;s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years. &#8220;This contract for Brooks to provide whole exome sequencing to the National Cancer Institute demonstrates the outstanding reputation of GENEWIZ in the cancer research community,&#8221; commented\u00a0Steve Schwartz, president and CEO of Brooks Automation. &#8220;We are proud that GENEWIZ&#8217;s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-413504","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire CHELMSFORD, Mass., Jan. 12, 2021 \/PRNewswire\/ &#8212;\u00a0Brooks Automation, Inc. (Nasdaq:BRKS) \u00a0announced today that GENEWIZ, the Company&#8217;s genomics analysis business, has been awarded one of six \u00a0Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation&#8217;s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years. &#8220;This contract for Brooks to provide whole exome sequencing to the National Cancer Institute demonstrates the outstanding reputation of GENEWIZ in the cancer research community,&#8221; commented\u00a0Steve Schwartz, president and CEO of Brooks Automation. &#8220;We are proud that GENEWIZ&#8217;s &hellip; Continue reading &quot;Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-12T21:09:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute\",\"datePublished\":\"2021-01-12T21:09:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/\"},\"wordCount\":484,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/653251\\\/Brooks_Automation_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/\",\"name\":\"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/653251\\\/Brooks_Automation_Logo.jpg\",\"datePublished\":\"2021-01-12T21:09:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/653251\\\/Brooks_Automation_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/653251\\\/Brooks_Automation_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/","og_locale":"en_US","og_type":"article","og_title":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk","og_description":"PR Newswire CHELMSFORD, Mass., Jan. 12, 2021 \/PRNewswire\/ &#8212;\u00a0Brooks Automation, Inc. (Nasdaq:BRKS) \u00a0announced today that GENEWIZ, the Company&#8217;s genomics analysis business, has been awarded one of six \u00a0Genome Characterization Center Indefinite Delivery Indefinite Quantity (IDIQ) contracts from the National Cancer Institute (NCI). The NCI, the nation&#8217;s leader in cancer research and part of the National Institutes of Health (NIH), chose GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics for a period of three years. &#8220;This contract for Brooks to provide whole exome sequencing to the National Cancer Institute demonstrates the outstanding reputation of GENEWIZ in the cancer research community,&#8221; commented\u00a0Steve Schwartz, president and CEO of Brooks Automation. &#8220;We are proud that GENEWIZ&#8217;s &hellip; Continue reading \"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-12T21:09:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute","datePublished":"2021-01-12T21:09:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/"},"wordCount":484,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/","name":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg","datePublished":"2021-01-12T21:09:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/653251\/Brooks_Automation_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brooks-announces-genewiz-selected-as-genome-characterization-center-by-the-national-cancer-institute\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Brooks Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=413504"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/413504\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=413504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=413504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=413504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}